Efficacy and its predictor in microwave ablation for severe secondary hyperparathyroidism in patients undergoing haemodialysis

References

• Madsen CM, Jorgensen HL, Lind B, Ogarrio HW, Riis T, Schwarz P, et al. Secondary hyperparathyroidism and mortality in hip fracture patients compared to a control group from general practice. Injury 2012;43:1052–7.
   PubMed Web of Science ®Google Scholar
• Huang C, Shapses SA, Wang X. Association of plasma parathyroid hormone with metabolic syndrome and risk for cardiovascular disease. Endocr Pract 2013;19:712–17.
   PubMed Web of Science ®Google Scholar
• Davies EW, Matza LS, Worth G, Feeny DH, Kostelec J, Soroka S, et al. Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis. Health Qual Life Outcomes 2015;13:90.
   PubMed Web of Science ®Google Scholar
• Brancaccio D, Cozzolino M, Cannella G, Messa P, Bonomini M, Cancarini G, et al. Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortality. Blood Purif 2011;32:124–32.
   PubMed Web of Science ®Google Scholar
• Kazama JJ. Japanese society of dialysis therapy treatment guidelines for secondary hyperparathyroidism. Ther Apher Dial 2007;11:S44–S47.
   PubMedGoogle Scholar
• Rodriguez M, Rodriguez-Ortiz ME. Advances in pharmacotherapy for secondary hyperparathyroidism. Expert Opin Pharmacother 2015;16:1703–16.
   PubMed Web of Science ®Google Scholar
• Ivarsson KM, Akaberi S, Isaksson E, Reihner E, Rylance R, Prutz KG, et al. The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism. Nephrol Dial Transplant 2015;30:2027–33.
   PubMed Web of Science ®Google Scholar
• Komaba H, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Fukagawa M. Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int 2015;88:350–9.
   PubMed Web of Science ®Google Scholar
• Tsai WC, Peng YS, Yang JY, Hsu SP, Wu HY, Pai MF, et al. Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience. Blood Purif 2013;36:116–21.
   PubMed Web of Science ®Google Scholar
• Lin HC, Chen CL, Lin HS, Chou KJ, Fang HC, Liu SI, et al. Parathyroidectomy improves cardiovascular outcome in nondiabetic dialysis patients with secondary hyperparathyroidism. Clin Endocrinol (Oxf) 2014;80:508–15.
   PubMed Web of Science ®Google Scholar
• Ma TL, Hung PH, Jong IC, Hiao CY, Hsu YH, Chiang PC, et al. Parathyroidectomy is associated with reduced mortality in hemodialysis patients with secondary hyperparathyroidism. Biomed Res Int 2015;2015:639587.
   PubMedGoogle Scholar
• Xu SY, Wang Y, Xie Q, Wu HY. Percutaneous sonography-guided radiofrequency ablation in the management of parathyroid adenoma. Singapore Med J 2013;54:e137–40.
   PubMed Web of Science ®Google Scholar
• Andrioli M, Riganti F, Pacella CM, Valcavi R. Long-term effectiveness of ultrasound-guided laser ablation of hyperfunctioning parathyroid adenomas: present and future perspectives. Am J Roentgenol 2012;199:1164–8.
   PubMed Web of Science ®Google Scholar
• Jiang T, Chen F, Zhou X, Hu Y, Zhao Q. Percutaneous ultrasound-guided laser ablation with contrast-enhanced ultrasonography for hyperfunctioning parathyroid adenoma: a preliminary case series. Int J Endocrin 2015;2015:673604.
   PubMed Web of Science ®Google Scholar
• Zhang NN, Lu W, Cheng XJ, Liu JY, Zhou YH, Li F. High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence. Clin Radiol 2015;70:1237–43.
   PubMed Web of Science ®Google Scholar
• Hernandez JI, Cepeda MF, Valdes F, Guerrero GD. Microwave ablation: state-of-the-art review. Onco Targets Ther 2015;8:1627–32.
   PubMed Web of Science ®Google Scholar
• Zhang JQ, Qiu M, Sheng JG, Lu F, Zhao LL, Zhang H, et al. Ultrasound-guided percutaneous thermal ablation for benign parathyroid nodules. Acad J Sec Milit Med Univ 2013;33:362–70.
   Google Scholar
• KDIGO. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009:S1–S130.
   Google Scholar
• Yu MA, Yao L, Zhang L, Peng L, Zhuo L, Zhang Y, et al. Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: a retrospective pilot study. Int J Hyperthermia 2016;32:180–6.
   PubMed Web of Science ®Google Scholar
• Yu L, Gou CL, Li F, Feng ZY. The therapeutic effect of full ablation and partial ablation of parathyroid for secondary hyperparathyroidism: a comparison study. J Interven Radiol 2015;6:498–501.
   Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:S1–S201.
   PubMed Web of Science ®Google Scholar
• Bashir SO, Omer HA, Aamer MA, Somialy R, Morsy MD. Tolerance and efficacy of a low dose of the calcimimetic agent cinacalcet in controlling moderate to severe secondary hyperparathyroidism in hemodialysis patients. Saudi J Kidney Dis Transpl 2015;26:1135–41.
   PubMed Web of Science ®Google Scholar
• Adda G, Scillitani A, Epaminonda P, Di LS, Motta F, Cecconi P, et al. Ultrasound-guided laser thermal ablation for parathyroid adenomas: analysis of three cases with a three-year follow-up. Horm Res 2006;65:231–4.
   PubMedGoogle Scholar
• Wang R, Jiang T, Chen Z, Chen J. Regression of calcinosis following treatment with radiofrequency thermoablation for severe secondary hyperparathyroidism in a hemodialysis patient. Intern Med 2013;52:583–7.
   PubMed Web of Science ®Google Scholar
• Pacella CM, Mauri G, Achille G, Barbaro D, Bizzarri G, De Feo P, et al. Outcomes and risk factors for complications of laser ablation for thyroid nodules: a multicenter study on 1531 patients. J Clin Endocrinol Metab 2015;100:3903–10.
   PubMed Web of Science ®Google Scholar
• Mauri G, Cova L, Ierace T, Baroli A, Di Mauro E, Pacella CM, et al. Treatment of etastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Inter Rad 2016;39:1023–30.
   PubMed Web of Science ®Google Scholar
• Poulou LS, Botsa E, Thanou I, Ziakas PD, Thanos L. Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Hepatol 2015;7:1054–63.
   PubMed Web of Science ®Google Scholar
• Inic Z, Inic M, Jancic S, Paunovic I, Tatic S, Tausanovic K, et al. The relationship between proliferation activity and parathyroid hormone levels in parathyroid tumors. J Buon 2015;20:562–6.
   PubMed Web of Science ®Google Scholar
• Duan K, Gomez Hernandez K, Mete O. Clinicopathological correlates of hyperparathyroidism. J Clin Pathol 2015;68:771–87.
   PubMed Web of Science ®Google Scholar
• Lewin E, Olgaard K. Influence of parathyroid mass on the regulation of PTH secretion. Kidney Int Suppl 2006:102:S16–S21.
   Google Scholar
• Kakuta T, Tanaka R, Kanai G, Miyamoto Y, Inagaki M, Suzuki H, et al. Relationship between the weight of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism. Ther Apher Dial 2008;12:385–90.
   PubMed Web of Science ®Google Scholar
• Moldovan D, Racasan S, Kacso IM, Rusu C, Potra A, Bondor C, et al. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism. Int Urol Nephrol 2015;47:1871–7.
   PubMed Web of Science ®Google Scholar
• Pulgar BD, Jara CA, Gonzalez VG, Gonzalez DH. Surgical treatment of renal hyperparathyroidism. Experience in 71 patients. Rev Med Chil 2015;143:190–6.
   PubMed Web of Science ®Google Scholar
• Stracke S, Keller F, Steinbach G, Henne-Bruns D, Wuerl P. Long-term outcome after total parathyroidectomy for the management of secondary hyperparathyroidism. Nephron Clin Pract 2009;111:c102–9.
   PubMed Web of Science ®Google Scholar
• Stanbury SW, Lumb GA, Nicholson WF. Elective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet 1960;1:793–9.
   PubMed Web of Science ®Google Scholar
• Fe M. Total parathyroidectomy in renal hyperparathyroidism. W V Med J 1965;61:250–5.
   PubMedGoogle Scholar
• Jia X, Wang R, Zhang C, Cui M, Xu D. Long-term outcomes of total parathyroidectomy with or without autoimplantation for hyperparathyroidism in chronic kidney disease: a meta-analysis. Ther Apher Dial 2015;19:477–85.
   PubMed Web of Science ®Google Scholar